Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 37

Results For "2022"

1412 News Found

GMM Pfaudler Q4 FY23 Consolidated PAT jumps to Rs. 38.47 Cr
News | May 26, 2023

GMM Pfaudler Q4 FY23 Consolidated PAT jumps to Rs. 38.47 Cr

The company has reported total income of Rs. 880.59 crores during the period ended March 31, 2023


Piramal Pharma posts Q4 FY23 consolidated PAT at Rs. 50.11 Cr
News | May 25, 2023

Piramal Pharma posts Q4 FY23 consolidated PAT at Rs. 50.11 Cr

The company has reported total income of Rs. 2188.08 crores during the period ended March 31, 2023


JB Pharma records revenue growth of 22% to Rs. 762 Cr
News | May 25, 2023

JB Pharma records revenue growth of 22% to Rs. 762 Cr

Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23


Neutec introduces the oCelloscope automated microbial live-cell imaging technology
News | May 24, 2023

Neutec introduces the oCelloscope automated microbial live-cell imaging technology

The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development


Biocon posts Q4 FY23 consolidated PAT at Rs. 313.2 Cr
News | May 24, 2023

Biocon posts Q4 FY23 consolidated PAT at Rs. 313.2 Cr

The company has reported total income of Rs. 3928.8 crores during the period ended March 31, 2023


Sun Pharma Advanced Research Company posts Q4 FY23 loss at Rs. 81.99 Cr
News | May 23, 2023

Sun Pharma Advanced Research Company posts Q4 FY23 loss at Rs. 81.99 Cr

The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023


Anuh Pharma posts Q4 FY23 PAT at Rs. 9.62 Cr
News | May 22, 2023

Anuh Pharma posts Q4 FY23 PAT at Rs. 9.62 Cr

Anuh Pharma has reported total income of Rs. 158.34 crores during the period ended March 31, 2023


Eris Lifesciences posts consolidated Q4FY23 PAT at Rs. 65.41 Cr
News | May 22, 2023

Eris Lifesciences posts consolidated Q4FY23 PAT at Rs. 65.41 Cr

Eris Lifesciences has reported total income of Rs. 403.80 crores during the period ended March 31, 2023


GlaxoSmithKline Pharmaceuticals posts consolidated Q4 FY2023 PAT at Rs. 133.43 Cr
News | May 22, 2023

GlaxoSmithKline Pharmaceuticals posts consolidated Q4 FY2023 PAT at Rs. 133.43 Cr

The company has reported total income of Rs. 815.11 crores during the period ended March 31, 2023


Mandaviya to inaugurate conference on 'India Pharma & India Medical Devices’ on May 26-27
Policy | May 22, 2023

Mandaviya to inaugurate conference on 'India Pharma & India Medical Devices’ on May 26-27

8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector